| Basics |
Array Technologies, Inc.
Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
|
| IPO Date: |
October 15, 2020 |
| Sector: |
Technology |
| Industry: |
Solar |
| Market Cap: |
$1.37B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.51 | 3.31%
|
| Avg Daily Range (30 D): |
$0.28 | 3.20%
|
| Avg Daily Range (90 D): |
$0.34 | 3.93%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
4.44M |
| Avg Daily Volume (30 D): |
4.45M |
| Avg Daily Volume (90 D): |
5.63M |
| Trade Size |
| Avg Trade Size (Sh.): |
123 |
| Avg Trade Size (Sh.) (30 D): |
139 |
| Avg Trade Size (Sh.) (90 D): |
140 |
| Institutional Trades |
| Total Inst.Trades: |
6,146 |
| Avg Inst. Trade: |
$2.3M |
| Avg Inst. Trade (30 D): |
$3.06M |
| Avg Inst. Trade (90 D): |
$2.82M |
| Avg Inst. Trade Volume: |
.16M |
| Avg Inst. Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.03M |
| Avg Closing Trade (30 D): |
$4.52M |
| Avg Closing Trade (90 D): |
$4.91M |
| Avg Closing Volume: |
369.72K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$.12
|
$.19
|
|
Diluted EPS
|
|
$.12
|
$.19
|
|
Revenue
|
$
|
$ 393.49M
|
$ 362.24M
|
|
Gross Profit
|
$
|
$ 105.67M
|
$ 97.12M
|
|
Net Income / Loss
|
$
|
$ 33.5M
|
$ 43.26M
|
|
Operating Income / Loss
|
$
|
$ 45.45M
|
$ 46.38M
|
|
Cost of Revenue
|
$
|
$ 287.82M
|
$ 265.12M
|
|
Net Cash Flow
|
$
|
$ -155.67M
|
$ 29.28M
|
|
PE Ratio
|
|
|
|
|
|
|
